Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prochymal for Treatment-Refractory Crohn's Disease
NCT00482092Phase 3Completed
- Sponsor
- Mesoblast Ltd
- Start
- Sep 2007
- Primary completion
- Sep 2014
- Countries
- 4
01
Overview
A Phase 3 trial of remestemcel-L-rknd in Crohn's disease, sponsored by Mesoblast Ltd. Started Sep 2007; status: completed.
02
Drugs
remestemcel-L-rknd
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00482092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482092.